target,target_id,target_uniprot,target_species,ligand,ligand_id,ligand_species,ligand_pubchem_cid,smiles,inchi,inchikey,type,action,action_comment,endogenous,primary_target,concentration_range,affinity_parameter,affinity_high,affinity_median,affinity_low,original_affinity_units,original_affinity_low_nm,original_affinity_median_nm,original_affinity_high_nm,original_affinity_relation,assay_description,receptor_site,ligand_context,pubmed_id
cyclin dependent kinase 4,1976,P11802,Human,AT-7519,5662,,11338033,O=C(c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl)NC1CCNCC1,"InChI=1S/C16H17Cl2N5O2/c17-10-2-1-3-11(18)13(10)15(24)22-12-8-20-23-14(12)16(25)21-9-4-6-19-7-5-9/h1-3,8-9,19H,4-7H2,(H,20,23)(H,21,25)(H,22,24)",OVPNQJVDAFNBDN-UHFFFAOYSA-N,Inhibitor,Inhibition,,,,,pIC50,,7.0,,IC50,,100.0,,=,,,,19174555,
cyclin dependent kinase 4,1976,P11802,Human,BMS-387032,5670,,3025986,O=C(C1CCNCC1)Nc1ncc(s1)SCc1ncc(o1)C(C)(C)C,"InChI=1S/C17H24N4O2S2/c1-17(2,3)12-8-19-13(23-12)10-24-14-9-20-16(25-14)21-15(22)11-4-6-18-7-5-11/h8-9,11,18H,4-7,10H2,1-3H3,(H,20,21,22)",OUSFTKFNBAZUKL-UHFFFAOYSA-N,Inhibitor,Inhibition,,,,,pKi,,6.03,,Ki,,925.0,,=,,,,23252711,
cyclin dependent kinase 4,1976,P11802,Human,alvocidib,5680,,5287969,CN1CC[C@@H]([C@@H](C1)O)c1c(O)cc(c2c1oc(cc2=O)c1ccccc1Cl)O,"InChI=1S/C21H20ClNO5/c1-23-7-6-12(17(27)10-23)19-14(24)8-15(25)20-16(26)9-18(28-21(19)20)11-4-2-3-5-13(11)22/h2-5,8-9,12,17,24-25,27H,6-7,10H2,1H3/t12-,17+/m0/s1",BIIVYFLTOXDAOV-YVEFUNNKSA-N,Inhibitor,Inhibition,,,yes,,pKi,,7.19,,Ki,,65.0,,=,,,,8674031,
cyclin dependent kinase 4,1976,P11802,Human,R547,5707,,6918852,COc1ccc(c(c1C(=O)c1cnc(nc1N)NC1CCN(CC1)S(=O)(=O)C)F)F,"InChI=1S/C18H21F2N5O4S/c1-29-13-4-3-12(19)15(20)14(13)16(26)11-9-22-18(24-17(11)21)23-10-5-7-25(8-6-10)30(2,27)28/h3-4,9-10H,5-8H2,1-2H3,(H3,21,22,23,24)",JRNJNYBQQYBCLE-UHFFFAOYSA-N,Inhibitor,Inhibition,,,yes,,pKi,,9.0,,Ki,,1.0,,=,Assayed using CDK4/cyclin D1 complex.,,,17121911,
cyclin dependent kinase 4,1976,P11802,Human,CGP74514A,5945,,2794188,CCn1cnc2c1nc(N[C@@H]1CCCC[C@@H]1N)nc2Nc1cccc(c1)Cl,"InChI=1S/C19H24ClN7/c1-2-27-11-22-16-17(23-13-7-5-6-12(20)10-13)25-19(26-18(16)27)24-15-9-4-3-8-14(15)21/h5-7,10-11,14-15H,2-4,8-9,21H2,1H3,(H2,23,24,25,26)/t14-,15+/m0/s1",UTBSBSOBZHXMHI-LSDHHAIUSA-N,Inhibitor,Inhibition,,,,,pIC50,,5.52,,IC50,,3000.0,,=,<i>In vitro</i> inhibition of human CDK4/cyclin D.,,,30234987,
cyclin dependent kinase 4,1976,P11802,Human,Cdk2 inhibitor IV,5949,,10202471,CCN(C(=O)c1ccc(cc1)Nc1nc(OCC2CCCCC2)c2c(n1)nc[nH]2)CC,"InChI=1S/C23H30N6O2/c1-3-29(4-2)22(30)17-10-12-18(13-11-17)26-23-27-20-19(24-15-25-20)21(28-23)31-14-16-8-6-5-7-9-16/h10-13,15-16H,3-9,14H2,1-2H3,(H2,24,25,26,27,28)",XHEQSRJCJTWWAH-UHFFFAOYSA-N,Inhibitor,Inhibition,,,,,pIC50,,5.26,,IC50,,5500.0,,=,CDK4/cyclin D complex used in assay,,,16170024,
cyclin dependent kinase 4,1976,P11802,Human,Cdk4 inhibitor,5950,,5330797,Brc1ccc2c(c1)[nH]c1c2c2c(=O)[nH]c(=O)c2c2c1[nH]c1c2cccc1,"InChI=1S/C20H10BrN3O2/c21-8-5-6-10-12(7-8)23-18-14(10)16-15(19(25)24-20(16)26)13-9-3-1-2-4-11(9)22-17(13)18/h1-7,22-23H,(H,24,25,26)",NMFKDDRQSNVETB-UHFFFAOYSA-N,Inhibitor,Inhibition,,,yes,,pIC50,,7.12,,IC50,,76.0,,=,CDK4/cyclin D1 complex,,,12747775,
cyclin dependent kinase 4,1976,P11802,Human,Cdk4 inhibitor II,5951,,3004085,COc1ccc(c2c1[nH]c1ccccc1c2=S)OC,"InChI=1S/C15H13NO2S/c1-17-11-7-8-12(18-2)14-13(11)15(19)9-5-3-4-6-10(9)16-14/h3-8H,1-2H3,(H,16,19)",KFAKESMKRPNZTM-UHFFFAOYSA-N,Inhibitor,Inhibition,,,,,pIC50,,6.7,,IC50,,200.0,,=,CDK4/cyclin D1 complex used in assay,,,10632371,
cyclin dependent kinase 4,1976,P11802,Human,Cdk4 inhibitor III,5952,,481747,Cc1ccc(cc1)NC1=CC(=O)c2c(C1=O)nc(s2)C,"InChI=1S/C15H12N2O2S/c1-8-3-5-10(6-4-8)17-11-7-12(18)15-13(14(11)19)16-9(2)20-15/h3-7,17H,1-2H3",HFPLHASLIOXVGS-UHFFFAOYSA-N,Inhibitor,Inhibition,,,,,pIC50,,8.22,,IC50,,6.0,,=,CDK4/cyclin D1 complex,,,10743948,
cyclin dependent kinase 4,1976,P11802,Human,fascaplysin,5969,,73293,O=C1c2c3[nH]c4c(c3cc[n+]2c2c1cccc2)cccc4,InChI=1S/C18H10N2O/c21-18-13-6-2-4-8-15(13)20-10-9-12-11-5-1-3-7-14(11)19-16(12)17(18)20/h1-10H/p+1,WYQIPCUPNMRAKP-UHFFFAOYSA-O,Inhibitor,Inhibition,,,yes,,pIC50,,6.46,,IC50,,350.0,,=,CDK4/cyclin D1 complex,,,10973815,
cyclin dependent kinase 4,1976,P11802,Human,purvalanol A,6030,,4987,OCC(C(C)C)Nc1nc(Nc2cccc(c2)Cl)c2c(n1)n(cn2)C(C)C,"InChI=1S/C19H25ClN6O/c1-11(2)15(9-27)23-19-24-17(22-14-7-5-6-13(20)8-14)16-18(25-19)26(10-21-16)12(3)4/h5-8,10-12,15,27H,9H2,1-4H3,(H2,22,23,24,25)",PMXCMJLOPOFPBT-UHFFFAOYSA-N,Inhibitor,Inhibition,,,,,pIC50,,6.07,,IC50,,850.0,,=,CDK4/cyclin D1 complex used in assay,,,9677190,
cyclin dependent kinase 4,1976,P11802,Human,SU9516,6045,,5289419,COc1ccc2c(c1)/C(=C/c1cnc[nH]1)/C(=O)N2,"InChI=1S/C13H11N3O2/c1-18-9-2-3-12-10(5-9)11(13(17)16-12)4-8-6-14-7-15-8/h2-7H,1H3,(H,14,15)(H,16,17)/b11-4-",QNUKRWAIZMBVCU-WCIBSUBMSA-N,Inhibitor,Inhibition,,,,,pIC50,,6.7,,IC50,,200.0,,=,CDK4/cyclin D1 complex used in assay,,,11507069,
cyclin dependent kinase 4,1976,P11802,Human,SU9516,6045,,5289419,COc1ccc2c(c1)/C(=C/c1cnc[nH]1)/C(=O)N2,"InChI=1S/C13H11N3O2/c1-18-9-2-3-12-10(5-9)11(13(17)16-12)4-8-6-14-7-15-8/h2-7H,1H3,(H,14,15)(H,16,17)/b11-4-",QNUKRWAIZMBVCU-WCIBSUBMSA-N,Inhibitor,Inhibition,,,,,pIC50,,5.77,,IC50,,1700.0,,=,<i>In vitro</i> inhibition of CDK4/cyclin D.,,,30234987,
cyclin dependent kinase 4,1976,P11802,Human,palbociclib,7380,,5330286,CC(=O)c1c(C)c2cnc(nc2n(c1=O)C1CCCC1)Nc1ccc(cn1)N1CCNCC1,"InChI=1S/C24H29N7O2/c1-15-19-14-27-24(28-20-8-7-18(13-26-20)30-11-9-25-10-12-30)29-22(19)31(17-5-3-4-6-17)23(33)21(15)16(2)32/h7-8,13-14,17,25H,3-6,9-12H2,1-2H3,(H,26,27,28,29)",AHJRHEGDXFFMBM-UHFFFAOYSA-N,Inhibitor,Inhibition,,,,,pIC50,,8.49,,IC50,,3.2,,=,,,,31330105,
cyclin dependent kinase 4,1976,P11802,Human,palbociclib,7380,,5330286,CC(=O)c1c(C)c2cnc(nc2n(c1=O)C1CCCC1)Nc1ccc(cn1)N1CCNCC1,"InChI=1S/C24H29N7O2/c1-15-19-14-27-24(28-20-8-7-18(13-26-20)30-11-9-25-10-12-30)29-22(19)31(17-5-3-4-6-17)23(33)21(15)16(2)32/h7-8,13-14,17,25H,3-6,9-12H2,1-2H3,(H,26,27,28,29)",AHJRHEGDXFFMBM-UHFFFAOYSA-N,Inhibitor,Inhibition,,,yes,,pIC50,,7.96,,IC50,,11.0,,=,,,,15542782,
cyclin dependent kinase 4,1976,P11802,Human,palbociclib,7380,,5330286,CC(=O)c1c(C)c2cnc(nc2n(c1=O)C1CCCC1)Nc1ccc(cn1)N1CCNCC1,"InChI=1S/C24H29N7O2/c1-15-19-14-27-24(28-20-8-7-18(13-26-20)30-11-9-25-10-12-30)29-22(19)31(17-5-3-4-6-17)23(33)21(15)16(2)32/h7-8,13-14,17,25H,3-6,9-12H2,1-2H3,(H,26,27,28,29)",AHJRHEGDXFFMBM-UHFFFAOYSA-N,Inhibitor,Inhibition,,,,,pIC50,,7.36,,IC50,,44.0,,=,,,,,
cyclin dependent kinase 4,1976,P11802,Human,abemaciclib,7382,,46220502,CCN1CCN(CC1)Cc1ccc(nc1)Nc1ncc(c(n1)c1cc(F)c2c(c1)n(C(C)C)c(n2)C)F,"InChI=1S/C27H32F2N8/c1-5-35-8-10-36(11-9-35)16-19-6-7-24(30-14-19)33-27-31-15-22(29)25(34-27)20-12-21(28)26-23(13-20)37(17(2)3)18(4)32-26/h6-7,12-15,17H,5,8-11,16H2,1-4H3,(H,30,31,33,34)",UZWDCWONPYILKI-UHFFFAOYSA-N,Inhibitor,Inhibition,,,,,pIC50,,8.7,,IC50,,2.0,,=,CDK4/cyclin D1 complex expressed in and purified from insect cells. Assays used the methanesulfonate salt of the compound.,,,24919854,
cyclin dependent kinase 4,1976,P11802,Human,ribociclib,7383,,44631912,CN(C(=O)c1cc2c(n1C1CCCC1)nc(nc2)Nc1ccc(cn1)N1CCNCC1)C,"InChI=1S/C23H30N8O/c1-29(2)22(32)19-13-16-14-26-23(28-21(16)31(19)17-5-3-4-6-17)27-20-8-7-18(15-25-20)30-11-9-24-10-12-30/h7-8,13-15,17,24H,3-6,9-12H2,1-2H3,(H,25,26,27,28)",RHXHGRAEPCAFML-UHFFFAOYSA-N,Inhibitor,Inhibition,,,yes,,pIC50,,8.0,,IC50,,10.0,,=,,,,,
cyclin dependent kinase 4,1976,P11802,Human,RGB-286638,7744,,11285002,COCCN1CCN(CC1)Cc1ccc(cc1)c1n[nH]c2c1C(=O)c1c2cccc1NC(=O)NN1CCOCC1,"InChI=1S/C29H35N7O4/c1-39-16-13-34-9-11-35(12-10-34)19-20-5-7-21(8-6-20)26-25-27(32-31-26)22-3-2-4-23(24(22)28(25)37)30-29(38)33-36-14-17-40-18-15-36/h2-8H,9-19H2,1H3,(H,31,32)(H2,30,33,38)",XLSYZSRXVVCHLS-UHFFFAOYSA-N,Inhibitor,Inhibition,,,yes,,pIC50,,8.4,,IC50,,4.0,,=,in association with cyclin D1,,,23807770,
cyclin dependent kinase 4,1976,P11802,Human,purvalanol B,7806,,448991,OC[C@@H](C(C)C)Nc1nc(Nc2ccc(c(c2)Cl)C(=O)O)c2c(n1)n(cn2)C(C)C,"InChI=1S/C20H25ClN6O3/c1-10(2)15(8-28)24-20-25-17(16-18(26-20)27(9-22-16)11(3)4)23-12-5-6-13(19(29)30)14(21)7-12/h5-7,9-11,15,28H,8H2,1-4H3,(H,29,30)(H2,23,24,25,26)/t15-/m0/s1",ZKDXRFMOHZVXSG-HNNXBMFYSA-N,Inhibitor,Inhibition,,,,,pIC50,,5.0,,IC50,,10000.0,,>,CDK4/cyclin D1 complex used in assay,,,9677190,
cyclin dependent kinase 4,1976,P11802,Human,riviciclib,7934,,23643976,OC[C@@H]1N(C)CC[C@H]1c1c(O)cc(c2c1oc(cc2=O)c1ccccc1Cl)O,"InChI=1S/C21H20ClNO5/c1-23-7-6-12(14(23)10-24)19-15(25)8-16(26)20-17(27)9-18(28-21(19)20)11-4-2-3-5-13(11)22/h2-5,8-9,12,14,24-26H,6-7,10H2,1H3/t12-,14+/m1/s1",QLUYMIVVAYRECT-OCCSQVGLSA-N,Inhibitor,Inhibition,,,yes,,pIC50,,7.2,,IC50,,63.0,,=,CDK4/cyclin D1 complex,,,17363486,
cyclin dependent kinase 4,1976,P11802,Human,milciclib,7938,,16718576,CNC(=O)c1nn(c2c1C(C)(C)Cc1c2nc(nc1)Nc1ccc(cc1)N1CCN(CC1)C)C,"InChI=1S/C25H32N8O/c1-25(2)14-16-15-27-24(29-20(16)22-19(25)21(23(34)26-3)30-32(22)5)28-17-6-8-18(9-7-17)33-12-10-31(4)11-13-33/h6-9,15H,10-14H2,1-5H3,(H,26,34)(H,27,28,29)",RXZMYLDMFYNEIM-UHFFFAOYSA-N,Inhibitor,Inhibition,,,,,pIC50,,6.8,,IC50,,160.0,,=,CDK4/cyclin D1 complex,,,19603809,
cyclin dependent kinase 4,1976,P11802,Human,milciclib,7938,,16718576,CNC(=O)c1nn(c2c1C(C)(C)Cc1c2nc(nc1)Nc1ccc(cc1)N1CCN(CC1)C)C,"InChI=1S/C25H32N8O/c1-25(2)14-16-15-27-24(29-20(16)22-19(25)21(23(34)26-3)30-32(22)5)28-17-6-8-18(9-7-17)33-12-10-31(4)11-13-33/h6-9,15H,10-14H2,1-5H3,(H,26,34)(H,27,28,29)",RXZMYLDMFYNEIM-UHFFFAOYSA-N,Inhibitor,Inhibition,,,,,pIC50,,6.66,,IC50,,220.0,,=,<i>In vitro</i> inhibition of CDK4/cyclin D.,,,30234987,
cyclin dependent kinase 4,1976,P11802,Human,compound 9b [PMID: 18986805],8160,,11675054,CNC(=O)c1ccc(cc1F)Nc1nccc(n1)c1cnc(n1C(C)C)C,"InChI=1S/C19H21FN6O/c1-11(2)26-12(3)23-10-17(26)16-7-8-22-19(25-16)24-13-5-6-14(15(20)9-13)18(27)21-4/h5-11H,1-4H3,(H,21,27)(H,22,24,25)",OCUYCOQPRGFQEV-UHFFFAOYSA-N,Inhibitor,Inhibition,,,,,pIC50,,7.3,,IC50,,50.0,,=,,,,18986805,
cyclin dependent kinase 4,1976,P11802,Human,Ro-0505124,8203,,9911652,CN1CCN(CC1)c1ccc(cc1)Nc1nc(c(s1)C(=O)c1ccc2c(c1)OCCO2)N,"InChI=1S/C23H25N5O3S/c1-27-8-10-28(11-9-27)17-5-3-16(4-6-17)25-23-26-22(24)21(32-23)20(29)15-2-7-18-19(14-15)31-13-12-30-18/h2-7,14H,8-13,24H2,1H3,(H,25,26)",YGEYFDLYGXSZCP-UHFFFAOYSA-N,Inhibitor,Inhibition,,,yes,,pIC50,,7.7,,IC50,,20.0,,=,,,,,
cyclin dependent kinase 4,1976,P11802,Human,trilaciclib,9626,,68029831,CN1CCN(CC1)c1ccc(nc1)Nc1ncc2c(n1)n1c(c2)C(=O)NCC21CCCCC2,"InChI=1S/C24H30N8O/c1-30-9-11-31(12-10-30)18-5-6-20(25-15-18)28-23-26-14-17-13-19-22(33)27-16-24(7-3-2-4-8-24)32(19)21(17)29-23/h5-6,13-15H,2-4,7-12,16H2,1H3,(H,27,33)(H,25,26,28,29)",PDGKHKMBHVFCMG-UHFFFAOYSA-N,Inhibitor,Inhibition,,,,,pIC50,,9.0,,IC50,,1.0,,=,Inhibition of CDK4/cyclin D1,,,26826116,
cyclin dependent kinase 4,1976,P11802,Human,trilaciclib,9626,,68029831,CN1CCN(CC1)c1ccc(nc1)Nc1ncc2c(n1)n1c(c2)C(=O)NCC21CCCCC2,"InChI=1S/C24H30N8O/c1-30-9-11-31(12-10-30)18-5-6-20(25-15-18)28-23-26-14-17-13-19-22(33)27-16-24(7-3-2-4-8-24)32(19)21(17)29-23/h5-6,13-15H,2-4,7-12,16H2,1H3,(H,27,33)(H,25,26,28,29)",PDGKHKMBHVFCMG-UHFFFAOYSA-N,Inhibitor,Inhibition,,,,,pKd,,10.0,,Kd,,0.1,,=,Inhibition of CDK4/cyclin D3,,,26826116,
cyclin dependent kinase 4,1976,P11802,Human,voruciclib,9923,,67409219,OC[C@@H]1N(C)CC[C@H]1c1c(O)cc(c2c1oc(cc2=O)c1ccc(cc1Cl)C(F)(F)F)O,"InChI=1S/C22H19ClF3NO5/c1-27-5-4-12(14(27)9-28)19-15(29)7-16(30)20-17(31)8-18(32-21(19)20)11-3-2-10(6-13(11)23)22(24,25)26/h2-3,6-8,12,14,28-30H,4-5,9H2,1H3/t12-,14+/m1/s1",MRPGRAKIAJJGMM-OCCSQVGLSA-N,Inhibitor,Inhibition,,,,,pIC50,,7.05,,IC50,,90.0,,=,Inhibition of CDK4/cyclinD1.,,,26606677,
cyclin dependent kinase 4,1976,P11802,Human,lerociclib,10313,,86269224,CC(N1CCN(CC1)c1ccc(nc1)Nc1ncc2c(n1)n1c(c2)C(=O)NCC21CCCCC2)C,"InChI=1S/C26H34N8O/c1-18(2)32-10-12-33(13-11-32)20-6-7-22(27-16-20)30-25-28-15-19-14-21-24(35)29-17-26(8-4-3-5-9-26)34(21)23(19)31-25/h6-7,14-16,18H,3-5,8-13,17H2,1-2H3,(H,29,35)(H,27,28,30,31)",YPJRHEKCFKOVRT-UHFFFAOYSA-N,Inhibitor,Inhibition,,,,,pIC50,,9.0,,IC50,,1.0,,=,Inhibition of CDK4/cyclin D1,,,,
cyclin dependent kinase 4,1976,P11802,Human,CDK inhibitor 4.35,10357,,,NCCSc1nc(NCc2ccc(cc2)c2ccccn2)c2c(n1)c(n[nH]2)C(C)C,"InChI=1S/C22H25N7S/c1-14(2)18-19-20(29-28-18)21(27-22(26-19)30-12-10-23)25-13-15-6-8-16(9-7-15)17-5-3-4-11-24-17/h3-9,11,14H,10,12-13,23H2,1-2H3,(H,28,29)(H,25,26,27)",PCQPAKMJSYGXRE-UHFFFAOYSA-N,Inhibitor,Inhibition,,,,,pIC50,,6.22,,IC50,,603.0,,=,Inhibition of CDK4/cyclin D1 complex.,,,30943029,
cyclin dependent kinase 4,1976,P11802,Human,PF-06873600,10426,,134247638,FC(c1cc2cnc(nc2n(c1=O)[C@@H]1CCC[C@@]1(C)O)NC1CCN(CC1)S(=O)(=O)C)F,"InChI=1S/C20H27F2N5O4S/c1-20(29)7-3-4-15(20)27-17-12(10-14(16(21)22)18(27)28)11-23-19(25-17)24-13-5-8-26(9-6-13)32(2,30)31/h10-11,13,15-16,29H,3-9H2,1-2H3,(H,23,24,25)/t15-,20-/m1/s1",QIEKHLDZKRQLLN-FOIQADDNSA-N,Inhibitor,Inhibition,,,,,pKi,,8.86,,Ki,,1.37,,=,Evaluated in a CDK4/Cyclin D3 mobility shift assay.,,,,
cyclin dependent kinase 4,1976,P11802,Human,BSJ-03-204,10530,,,O=C(COc1cccc2c1C(=O)N(C2=O)C1CCC(=O)NC1=O)NCCCCN1CCN(CC1)c1ccc(nc1)Nc1ncc2c(n1)n(C1CCCC1)c(=O)c(c2C)C(=O)C,"InChI=1S/C43H48N10O8/c1-25-30-23-46-43(49-38(30)52(27-8-3-4-9-27)41(59)36(25)26(2)54)47-33-14-12-28(22-45-33)51-20-18-50(19-21-51)17-6-5-16-44-35(56)24-61-32-11-7-10-29-37(32)42(60)53(40(29)58)31-13-15-34(55)48-39(31)57/h7,10-12,14,22-23,27,31H,3-6,8-9,13,15-21,24H2,1-2H3,(H,44,56)(H,48,55,57)(H,45,46,47,49)",KDMOCOWXLQOXEB-UHFFFAOYSA-N,Inhibitor,Inhibition,,,,,pIC50,,7.57,,IC50,,26.9,,=,Inhibition of CDK4/cyclin D1 kinase activity in a biochemical assay.,,,30802347,
cyclin dependent kinase 4,1976,P11802,Human,BSJ-04-132,10531,,,O=C(COc1cccc2c1C(=O)N(C2=O)C1CCC(=O)NC1=O)NCCCCN1CCN(CC1)c1ccc(nc1)Nc1ncc2c(n1)n(C1CCCC1)c(c2)C(=O)N(C)C,"InChI=1S/C42H49N11O7/c1-49(2)40(58)31-22-26-23-45-42(48-37(26)52(31)27-8-3-4-9-27)46-33-14-12-28(24-44-33)51-20-18-50(19-21-51)17-6-5-16-43-35(55)25-60-32-11-7-10-29-36(32)41(59)53(39(29)57)30-13-15-34(54)47-38(30)56/h7,10-12,14,22-24,27,30H,3-6,8-9,13,15-21,25H2,1-2H3,(H,43,55)(H,47,54,56)(H,44,45,46,48)",GWLSXEHHNOBFOI-UHFFFAOYSA-N,Inhibitor,Inhibition,,,,,pIC50,,7.3,,IC50,,50.6,,=,Inhibition of CDK4/cyclin D1 kinase activity in a biochemical assay.,,,30802347,
cyclin dependent kinase 4,1976,P11802,Human,BSJ-03-123,10532,,137628658,O=C(COc1cccc2c1C(=O)N(C2=O)C1CCC(=O)NC1=O)NCCOCCOCCOCCN1CCN(CC1)c1ccc(nc1)Nc1ncc2c(n1)n(C1CCCC1)c(=O)c(c2C)C(=O)C,"InChI=1S/C47H56N10O11/c1-29-34-27-50-47(53-42(34)56(31-6-3-4-7-31)45(63)40(29)30(2)58)51-37-12-10-32(26-49-37)55-17-15-54(16-18-55)19-21-66-23-25-67-24-22-65-20-14-48-39(60)28-68-36-9-5-8-33-41(36)46(64)57(44(33)62)35-11-13-38(59)52-43(35)61/h5,8-10,12,26-27,31,35H,3-4,6-7,11,13-25,28H2,1-2H3,(H,48,60)(H,52,59,61)(H,49,50,51,53)",LUHCYAOYQIFNRN-UHFFFAOYSA-N,Inhibitor,Inhibition,,,,,pIC50,,6.97,,IC50,,106.0,,=,Inhibition of CDK4/cyclin D1 activity in a biochemical kinase assay.,,,30802347,
cyclin dependent kinase 4,1976,P11802,Human,dalpiciclib,11189,,,CC(=O)c1c(C)c2cnc(nc2n(c1=O)C1CCCC1)Nc1ccc(cn1)C1CCNCC1,"InChI=1S/C25H30N6O2/c1-15-20-14-28-25(29-21-8-7-18(13-27-21)17-9-11-26-12-10-17)30-23(20)31(19-5-3-4-6-19)24(33)22(15)16(2)32/h7-8,13-14,17,19,26H,3-6,9-12H2,1-2H3,(H,27,28,29,30)",SGJLSPUSUBJWHO-UHFFFAOYSA-N,Inhibitor,Inhibition,,,,,pIC50,,7.96,,IC50,,11.0,,=,,,,,
cyclin dependent kinase 4,1976,P11802,Human,cimpuciclib,11409,,134343855,O=C(c1ccc(nc1C)Nc1ncc(c(n1)c1ccc2c(c1)n(C(C)C)c(n2)C)F)N1CCC(CC1)NC1CC1,"InChI=1S/C30H35FN8O/c1-17(2)39-19(4)34-25-9-5-20(15-26(25)39)28-24(31)16-32-30(37-28)36-27-10-8-23(18(3)33-27)29(40)38-13-11-22(12-14-38)35-21-6-7-21/h5,8-10,15-17,21-22,35H,6-7,11-14H2,1-4H3,(H,32,33,36,37)",FDSYOFCVZBGPOV-UHFFFAOYSA-N,Inhibitor,Inhibition,,,,,pIC50,,9.31,,IC50,,0.49,,=,,,,,
cyclin dependent kinase 4,1976,P11802,Human,CP-10,11662,,138911323,Cc1c(c(=O)n(c2nc(ncc12)Nc1ncc(cc1)N1CCN(CC1)Cc1cn(nn1)CCOCCNc1cccc2c1C(=O)N(C2=O)C1CCC(=O)NC1=O)C1CCCC1)C=O,"InChI=1S/C43H47N13O7/c1-26-31-22-46-43(49-38(31)55(28-5-2-3-6-28)41(61)32(26)25-57)47-35-11-9-29(21-45-35)53-16-14-52(15-17-53)23-27-24-54(51-50-27)18-20-63-19-13-44-33-8-4-7-30-37(33)42(62)56(40(30)60)34-10-12-36(58)48-39(34)59/h4,7-9,11,21-22,24-25,28,34,44H,2-3,5-6,10,12-20,23H2,1H3,(H,48,58,59)(H,45,46,47,49)",MZTSDEMVUMXQFP-UHFFFAOYSA-N,Inhibitor,Inhibition,,,,,pIC50,,7.52,,IC50,,30.0,,=,,,,31330105,
cyclin dependent kinase 4,1976,P11802,Human,narazaciclib,11879,,56649281,C1(CCCC1)n1c(=O)c(cc2c1nc(nc2)Nc1ccc(cc1)N1CCN(CC1)C)C#N,"InChI=1S/C24H27N7O/c1-29-10-12-30(13-11-29)20-8-6-19(7-9-20)27-24-26-16-18-14-17(15-25)23(32)31(22(18)28-24)21-4-2-3-5-21/h6-9,14,16,21H,2-5,10-13H2,1H3,(H,26,27,28)",VADOZMZXXRBXNY-UHFFFAOYSA-N,Inhibitor,Inhibition,,,,,pIC50,,8.41,,IC50,,3.9,,=,CDK2/CyclinD1,,,24417566,
cyclin dependent kinase 4,1976,P11802,Human,tanuxiciclib,11885,,137150090,Nc1nccc(c1F)c1nc(c(cc1)O)c1nc(nc(c1)C)N,"InChI=1S/C15H13FN6O/c1-7-6-10(22-15(18)20-7)13-11(23)3-2-9(21-13)8-4-5-19-14(17)12(8)16/h2-6,23H,1H3,(H2,17,19)(H2,18,20,22)",UQHDKUFLWKTTDL-UHFFFAOYSA-N,Inhibitor,Inhibition,,,,,pIC50,,6.47,,IC50,,341.5,,=,CDK3/cyclinD,,,,
cyclin dependent kinase 4,1976,P11802,Human,crozbaciclib,12076,,129202507,Fc1c(nc(nc1)Nc1ncc(cc1)C1CCN(CC1)C)c1cc2C3(C(=Nc2c(c1)F)C)CCCC3,"InChI=1S/C28H30F2N6/c1-17-28(9-3-4-10-28)21-13-20(14-22(29)26(21)33-17)25-23(30)16-32-27(35-25)34-24-6-5-19(15-31-24)18-7-11-36(2)12-8-18/h5-6,13-16,18H,3-4,7-12H2,1-2H3,(H,31,32,34,35)",AEFFENQISAXIKE-UHFFFAOYSA-N,Inhibitor,Inhibition,,,,,pIC50,,8.52,,IC50,,3.0,,=,Inhibition of CDK4/cyclin D1 in vitro,,,29247857,
cyclin dependent kinase 4,1976,P11802,Human,inixaciclib,12078,,139390026,Fc1c(nc(nc1)Nc1ncc(cc1)C1CCN(CC1)C)c1cc(c2c(N(CCO2)C(C)C)c1)F,"InChI=1S/C26H30F2N6O/c1-16(2)34-10-11-35-25-20(27)12-19(13-22(25)34)24-21(28)15-30-26(32-24)31-23-5-4-18(14-29-23)17-6-8-33(3)9-7-17/h4-5,12-17H,6-11H2,1-3H3,(H,29,30,31,32)",YZSCPLGKKMSBMV-UHFFFAOYSA-N,Inhibitor,Inhibition,,,,,pIC50,,8.7,,IC50,,2.0,,=,,,,,
cyclin dependent kinase 4,1976,P11802,Human,ulecaciclib,12079,,126535127,C1(CCCC1)Nc1sc(c(n1)C)c1nc(ncc1F)Nc1ncc(cc1)CN1CCN(CC1)CC,"InChI=1S/C25H33FN8S/c1-3-33-10-12-34(13-11-33)16-18-8-9-21(27-14-18)31-24-28-15-20(26)22(32-24)23-17(2)29-25(35-23)30-19-6-4-5-7-19/h8-9,14-15,19H,3-7,10-13,16H2,1-2H3,(H,29,30)(H,27,28,31,32)",POFVJRKJJBFPII-UHFFFAOYSA-N,Inhibitor,Inhibition,,,,,pKi,,8.52,,Ki,,3.0,,=,Inhibition of CDK4/cyclin D1 in vitro,,,28156111,
